Therapeutic approach in insulin resistance with acanthosis nigricans

International Journal of Clinical Practice

Volumn 56, Issue 8, 2002, Pages 578-581

  Tankova, Tsvetalina ^a   Koev, D ^a   Dakovska, L ^a   Kirilov, G ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN;

ABDOMINAL DISEASE; ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DIARRHEA; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; BODY MASS INDEX; BODY WEIGHT; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; OBESITY;

EID: 0036775556     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Reaven GM. Role of insulin resistance in human disease: Banting lecture 1988. Diabetes 1988; 37: 1595-1607.
2. Brockow K, Steinkraus V, Runninger F et al. Acanthosis nigricans: a marker for hyperinsulinemia. Pediatr Dermatol 1995; 12: 323-326.
3. Hud JA, Cohen JB, Wagner JM, Cruz PD. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992; 128: 941-944.
4. Stuart CA, Driscoll MS, Lundquist KF et al. Acanthosis nigricans. J Basic Clin Physiol Pharmacol 1998; 9: 407-418.
5. Bener A, Lestringaut GG, Nyomba BL et al. Acanthosis nigricans hyperinsulinaemia and risk factors for cardiovascular disease. East Mediterr Health J 2000; 6(2-3): 416-424.
6. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000; 43: 148-155.
7. Freemark M, Bursey D. The effect of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001; 107: E55.
8. Rique S, Ibanez L, Marcos MV et al. Effect of metformin on androgens and insulin concenrations in type A insulin resistance syndrome. Diabetologia 2000; 43: 385-386.
9. Dagogo-Jack S, Santiago JV. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med 1997; 157: 1802-1817.
10. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 1998; 15: 539-553.
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
12. Tallaride RJ, Murray PB. Manual of pharmacologic calculations. Berlin: Springer-Verlag, 1981.
13. Gianani R, Pugliese A, Bonner-Weir S et al. Prognostically significant heteogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 1992; 3: 347-353.
14. Bingley PJ, Colman P, Eisenbarth GS et al. Standardization of IVGTT to predict IDDM. Diabetes Care 1992; 10: 1313-1316.
15. Vardi P, Crisa L, Jackson RA. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 1991; 34: 93-102.
16. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-419.
17. Kostner G. Enzymatic determinantion of cholesterol in high density lipoprotein fractions prapared by polyanion precipitation. Clin Chem 1976; 22: 695-698.
18. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23(1): 57-63.
19. Stunkard AJ. Current views on obesity. Am J Med 1996; 100: 230-236.
20. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119: 655-660.
21. UK Prospective Diabetes Study (UKPDS) group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
22. Stratton IM, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
23. Grodsky GM. An update on implications of phasic insulin secretion. In: Pickup J, Williams G, Eds. Textbook of diabetes, vol 1. Oxford: Blackwell Scientific Publications, 1997; 421-430.
24. Wallum BJ, Kahn SE, McCulloch DK et al. Insulin secretion in the normal and diabetic human. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds. International textbook of diabetes mellitus. Chichester: John Wiley & Sons, 1992; 285-301.
25. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a precarious balance between insulin action and insulin secretion. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds. International textbook of diabetes mellitus. Chichester: John Wiley & Sons, 1992; 569-633.
26. Crepaldi G, Del-Prato S. What therapy do our NIDDM patients need? Insulin releasers. Diabetes Res Clin Pract 1995; 28(suppl): S159-S165.
27. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-368.
28. Porte DJ. Beta-cells in type II diabetes mellitus. Banting lecture 1990. Diabetes 1991; 40: 166-180.
29. Warram JH, Sigal RJ, Martin BC et al. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med 1996; 13(suppl 6): S40-S45.